共 50 条
- [21] Effects of exenatide (exendin-4) on glycemic control and weight in patients with Type 2 diabetes treated with metformin and a sulfonylureaDIABETOLOGIA, 2004, 47 : A279 - A280Kendall, DMRiddle, MCZhuang, DKim, DDFineman, MSBaron, AD
- [22] Influence of antidepressant use on glycemic control in patients with diabetes mellitus: an open-label comparative studyBRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (05) : 783 - 784Derijks, H. J.Janknegt, R.Heerdink, E. R.De Koning, G. H. P.Krekels, M. M.Looij, B. J.Egberts, A. C. G.
- [23] INFLUENCE OF ANTIDEPRESSANT USE ON GLYCEMIC CONTROL IN PATIENTS WITH DIABETES MELLITUS: AN OPEN-LABEL COMPARATIVE STUDYBASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 39 - 39Derijks, H. J.Janknegt, R.Heerdink, E. R.de Koning, G. H.Krekels, M. M.Looij, B. J.Egberts, A. C.
- [24] Influence of Antidepressant Use on Glycemic Control in Patients With Diabetes Mellitus An Open-Label Comparative StudyJOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (04) : 405 - 408Derijks, Hieronymus J.Janknegt, RobertHeerdink, Eibert R.De Koning, Fred H. P.Krekels, Marielle M.Looij, Bert-JanEgberts, Antoine C. G.
- [25] Comparative efficacy of exenatide versus insulin glargine on glycemic control in type 2 diabetes mellitus patients inadequately treated with metformin monotherapyADVANCES IN MEDICAL SCIENCES, 2013, 58 (01): : 38 - 43Karagianni, P.Polyzos, S. A.Kartali, N.Zografou, ISambanis, C.
- [26] Exenatide BID vs. Insulin Lispro TIDM Added to Titrated Insulin Glargine QD in Metformin-Treated T2DM Patients Resulted in Similar Glycemic Control but Weight Loss and Less Hypoglycemia: The 4B StudyDIABETES, 2013, 62 : A17 - A18Diamant, MichaelaNauck, MichaelShaginian, RimmaMalone, JamesCleall, SimonDe Vries, DanielleHoogwerf, Byron J.Macconell, LeighWolffenbuttel, Bruce
- [27] LIRA-PRIME: A Randomized Trial in Primary Care Settings of Liraglutide vs. OAD for Glycemic Control in Patients with Type 2 Diabetes Not in Control on MetforminDIABETES, 2020, 69Unger, JeffKaltoft, MargitKolhe, DevayaniPanda, Jayant KumarSargin, MehmetWolthers, Benjamin OleZoghbi, Marouan
- [28] A Multicenter, Randomized, Open-Label Study to Compare the Effects of Gemigliptin Add-on or Escalation of Metformin Dose on Glycemic Control and Safety in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Metformin and SGLT-2 Inhibitors (SO GOOD Study)JOURNAL OF DIABETES RESEARCH, 2024, 2024Kim, Hae JinNoh, Jung HyunMoon, Min KyongChoi, Sung HeeKo, Seung-HyunRhee, Eun-JungHur, Kyu YeonJeong, In-Kyung
- [29] Preventive effect of ipragliflozin on nocturnal hypoglycemia in patients with type 2 diabetes treated with basal-bolus insulin therapy: An open-label, single-center, parallel, randomized control studyJOURNAL OF DIABETES INVESTIGATION, 2017, 8 (03) : 341 - 345Okajima, FumitakaNagamine, TomokoNakamura, YukoHattori, NaomiSugihara, HitoshiEmoto, Naoya
- [30] Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trialCURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (11) : 1797 - 1806Yao, JunGuo, XiaohuiSun, LiHan, PingLv, XiaofengZhang, XiuzhenMo, ZhaohuiYang, WenyingZhang, LihuiWang, ZhanjianZhu, LvyunLi, QuanminYang, TaoWang, WenboXue, YaomingShi, YongquanLu, JumingPeng, YongdeZhang, FanYan, DewenWang, DameiYu, Xuefeng